News
HSKA
--
0.00%
--
Heska Corp Shares Up 49.1% Since SmarTrend's Buy Recommendation (HSKA)
SmarTrend identified an Uptrend for Heska Corp (NASDAQ:HSKA) on October 8th, 2020 at $106.95. In approximately 3 months, Heska Corp has returned 49.14% as of today's recent price of $159.50.
Comtex SmarTrend(R) · 4d ago
Heska Corporation to Acquire Lacuna Diagnostics, a Pioneer and Market Leader in Point-of-Care Digital Cytology
, /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced today that the Company has entered into an agreement (the "Agreement") to ac...
PR Newswire - PRF · 6d ago
Heska Corporation to Acquire Lacuna Diagnostics, a Pioneer and Market Leader in Point-of-Care Digital Cytology
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced today that the Company has entered into an agreement (the "Agreement") to acquire 100% of Lacun...
PR Newswire · 6d ago
Heska Corporation Elects Dr. Joachim Hasenmaier to Board of Directors
, /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, appointed Dr. Joachim Hasenmaier, the former head of Boehringer Ingelheim Animal Health, to the C...
PR Newswire - PRF · 01/12 21:30
Heska Corporation Elects Dr. Joachim Hasenmaier to Board of Directors
PR Newswire · 01/12 21:30
Heska Corp Has Returned 47.6% Since SmarTrend Recommendation (HSKA)
SmarTrend identified an Uptrend for Heska Corp (NASDAQ:HSKA) on October 8th, 2020 at $106.95. In approximately 3 months, Heska Corp has returned 47.57% as of today's recent price of $157.83.
Comtex SmarTrend(R) · 01/06 18:49
Heska to Present at Upcoming J.P. Morgan Annual Healthcare Conference
, /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced that , Heska's President & Chief Executive Officer, will present at the 39 A...
PR Newswire - PRF · 01/05 13:30
37.6% Return Seen to Date on SmarTrend Heska Corp Call (HSKA)
SmarTrend identified an Uptrend for Heska Corp (NASDAQ:HSKA) on October 8th, 2020 at $106.95. In approximately 3 months, Heska Corp has returned 37.60% as of today's recent price of $147.16.
Comtex SmarTrend(R) · 12/29/2020 05:35
Heska (NASDAQ:HSKA) Has Debt But No Earnings; Should You Worry?
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Simply Wall St. · 12/21/2020 06:37
Uptrend Call Working As Heska Corp Stock Rises 38.1% (HSKA)
SmarTrend identified an Uptrend for Heska Corp (NASDAQ:HSKA) on October 8th, 2020 at $106.95. In approximately 2 months, Heska Corp has returned 38.10% as of today's recent price of $147.70.
Comtex SmarTrend(R) · 12/18/2020 18:19
Is HSKA A Good Stock To Buy Now?
Insider Monkey · 12/16/2020 03:29
Uptrend Call Working As Heska Corp Stock Rises 33.5% (HSKA)
SmarTrend identified an Uptrend for Heska Corp (NASDAQ:HSKA) on October 8th, 2020 at $106.95. In approximately 2 months, Heska Corp has returned 33.46% as of today's recent price of $142.74.
Comtex SmarTrend(R) · 12/10/2020 18:19
Heska Corporation to Present at the Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference
, /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced that , Heska's President & Chief Executive Officer, will participate in the Piper Sandler 32 Annual Virtual Healthcare Conference on .
PR Newswire - PRF · 11/24/2020 13:00
Heska Corporation to Present at the Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference
, /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced that , Heska's President & Chief Executive Officer, will participate in the Piper Sandler 32 Annual Virtual Healthcare Conference on .
PR Newswire - PRF · 11/24/2020 13:00
Heska Corporation to Present at the Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference
Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska's President & Chief Executive Officer, will participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference on Tuesday, December 1, 2020.
PR Newswire · 11/24/2020 13:00
Heska Corporation to Present at the Upcoming Piper Sandler 32nd Annual Virtual Healthcare Conference
PR Newswire · 11/24/2020 13:00
Raymond James Maintains Outperform on Heska, Raises Price Target to $145
Raymond James maintains Heska (NASDAQ:HSKA) with a Outperform and raises the price target from $140 to $145.
Benzinga · 11/19/2020 12:16
Heska Corporation Elects Robert L. Antin to Board of Directors
, /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, appointed , the Founder of VCA Antech, Inc., to the Company's Board of Directors (the "Board"), effective .
PR Newswire - PRF · 11/18/2020 13:01
Heska Corporation Elects Robert L. Antin to Board of Directors
, /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, appointed , the Founder of VCA Antech, Inc., to the Company's Board of Directors (the "Board"), effective .
PR Newswire - PRF · 11/18/2020 13:01
Heska Corporation Elects Robert L. Antin to Board of Directors
PR Newswire · 11/18/2020 13:00
Webull provides a variety of real-time HSKA stock news. You can receive the latest news about Heska through multiple platforms. This information may help you make smarter investment decisions.
About HSKA
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products. Its OVP segment includes private label vaccine and pharmaceutical production for cattle but also for other species, including equine, porcine, avian, feline and canine. All OVP products are sold by third parties under third-party labels. It focuses on supporting veterinarians in canine and feline healthcare space. It offers a line of veterinary blood testing and other instruments. It manufactures biological and pharmaceutical products for other animal health companies.
More